Rapport Therapeutics, Inc. Common Stock (RAPP) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$29.06
Day's range
$32.3

Rapport Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 08/13/2026 7.17 M $298.89 M   0.06% 15.11%
TRV GP V, LLC 08/10/2026 6.28 M $261.71 M   -11.98% 13.23%
ARCH VENTURE MANAGEMENT, LLC 08/14/2026 3.73 M $155.38 M   0.00% 7.85%
CAPITAL INTERNATIONAL INVESTORS 08/12/2026 2.92 M $121.76 M   -5.68% 6.16%
GOLDMAN SACHS GROUP INC 08/14/2026 2.91 M $121.28 M   -1.08% 6.13%
BLACKROCK, INC. 08/07/2026 2.70 M $112.50 M   7.73% 5.69%
CORMORANT ASSET MANAGEMENT, LP 08/14/2026 2.66 M $110.74 M   -10.14% 5.60%
SOFINNOVA INVESTMENTS, INC. 08/14/2026 1.90 M $79.36 M   0.00% 4.01%
JOHNSON & JOHNSON 08/06/2026 1.78 M $74.36 M   0.00% 3.76%
POLAR CAPITAL HOLDINGS PLC 08/14/2026 1.61 M $67.03 M   -2.07% 3.39%
BAKER BROS. ADVISORS LP 08/14/2026 1.55 M $64.47 M   0.00% 3.26%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 1.35 M $56.11 M   1.62% 2.84%
TRV GP VI, LLC 08/10/2026 969.22 K $40.39 M   0.00% 2.04%
STATE STREET CORP 08/07/2026 818.71 K $34.12 M   7.79% 1.72%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 793.45 K $33.07 M   9.95% 1.67%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 787.45 K $32.81 M   -9.12% 1.66%
PERCEPTIVE ADVISORS LLC 08/14/2026 773.34 K $32.23 M   14.75% 1.63%
VESTAL POINT CAPITAL, LP 08/14/2026 730.00 K $30.42 M   -49.17% 1.54%
ALLIANCEBERNSTEIN L.P. 08/14/2026 693.38 K $21.70 M   -4.73% 1.46%
UBS ASSET MANAGEMENT AMERICAS INC 08/13/2026 644.08 K $26.84 M   -29.90% 1.36%
SIREN, L.L.C. 08/13/2026 641.47 K $26.73 M   0.00% 1.35%
CAPITAL WORLD INVESTORS 08/12/2026 551.66 K $22.99 M   2.80% 1.16%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 08/14/2026 393.20 K $16.39 M   -36.64% 0.83%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 362.11 K $15.09 M   61.30% 0.76%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 359.94 K $15.00 M   12.16% 0.76%
CANDRIAM S.C.A. 08/13/2026 347.65 K $14.47 M   86.98% 0.73%
SIO CAPITAL MANAGEMENT, LLC 08/14/2026 307.66 K $12.82 M   -16.13% 0.65%
MORGAN STANLEY 08/13/2026 297.61 K $12.40 M   79.33% 0.63%
NORTHERN TRUST CORP 08/13/2026 277.31 K $11.56 M   16.52% 0.58%
KENNEDY CAPITAL MANAGEMENT LLC 08/14/2026 250.80 K $10.45 M   -2.58% 0.53%
BURKEHILL GLOBAL MANAGEMENT, LP 08/14/2026 250.00 K $10.42 M   0.00% 0.53%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 246.82 K $10.28 M   2.88% 0.52%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 246.82 K $10.28 M   100.00% 0.52%
ALGERT GLOBAL LLC 08/13/2026 223.82 K $9.33 M   100.00% 0.47%
INVESCO LTD. 08/14/2026 215.24 K $8.97 M   25.31% 0.45%
D. E. SHAW & CO., INC. 08/14/2026 214.83 K $8.95 M   22.45% 0.45%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 208.33 K $8.68 M   10.08% 0.44%
ENSIGN PEAK ADVISORS, INC 08/14/2026 165.55 K $6.90 M   -14.75% 0.35%
MILLENNIUM MANAGEMENT LLC 08/14/2026 154.91 K $6.46 M   -51.52% 0.33%
UBS GROUP AG 08/13/2026 151.17 K $6.30 M   -0.38% 0.32%
ADAGE CAPITAL PARTNERS GP, L.L.C. 08/14/2026 150.00 K $6.25 M   0.00% 0.32%
ARTIA GLOBAL PARTNERS LP 08/14/2026 138.51 K $5.77 M   0.00% 0.29%
SWEDBANK AB 07/15/2026 117.40 K $4.89 M   3.71% 0.25%
NUVEEN, LLC 08/11/2026 103.36 K $4.31 M   44.54% 0.22%
WALLEYE CAPITAL LLC 08/03/2026 102.16 K $4.26 M   816.42% 0.22%
WOODLINE PARTNERS LP 08/14/2026 97.54 K $4.06 M   100.00% 0.21%
TD ASSET MANAGEMENT INC 08/04/2026 91.88 K $3.83 M   -7.27% 0.19%
WELLINGTON MANAGEMENT GROUP LLP 08/14/2026 86.99 K $3.62 M   11.19% 0.18%
PRUDENTIAL FINANCIAL INC 08/12/2026 86.89 K $3.62 M   -24.33% 0.18%
CITADEL ADVISORS LLC 09/02/2026 82.44 K $3.44 M   100.00% 0.17%

Rapport Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 183 institutional investors and hedge funds held shares of Rapport Therapeutics Inc.. The most heavily invested institutionals were:

FMR LLC: 7.17 M

TRV GP V, LLC: 6.28 M

ARCH Venture Management, LLC: 3.73 M

Capital International Investors: 2.92 M

GOLDMAN SACHS GROUP INC: 2.91 M

BlackRock, Inc.: 2.7 M

108.52% of Rapport Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 53.37 M shares in the last 24 months. This purchase volume represents approximately $1.63 B in transactions.